224 related articles for article (PubMed ID: 33941111)
1. Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring.
Lee YYD; Nguyen DT; Moodie T; O'Brien R; McMaster A; Hickey A; Pritchard N; Poulsen P; Tabaksblat EM; Weber B; Worm E; Pryor D; Chu J; Hardcastle N; Booth J; Gebski V; Wang T; Keall P
BMC Cancer; 2021 May; 21(1):494. PubMed ID: 33941111
[TBL] [Abstract][Full Text] [Related]
2. The first clinical implementation of real-time 6 degree-of-freedom image-guided radiotherapy for liver SABR patients.
Sengupta C; Nguyen DT; Moodie T; Mason D; Luo J; Causer T; Liu SF; Brown E; Inskip L; Hazem M; Chao M; Wang T; Lee YY; van Gysen K; Sullivan E; Cosgriff E; Ramachandran P; Poulsen P; Booth J; O'Brien R; Greer P; Keall P
Radiother Oncol; 2024 Jan; 190():110031. PubMed ID: 38008417
[TBL] [Abstract][Full Text] [Related]
3. The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial.
Hewson EA; Nguyen DT; O'Brien R; Kim JH; Montanaro T; Moodie T; Greer PB; Hardcastle N; Eade T; Kneebone A; Hruby G; Hayden AJ; Turner S; Siva S; Tai KH; Hunter P; Sams J; Poulsen PR; Booth JT; Martin J; Keall PJ
Med Phys; 2019 Nov; 46(11):4725-4737. PubMed ID: 31446633
[TBL] [Abstract][Full Text] [Related]
4. Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial.
Zapatero A; Castro P; Roch M; Carnero PR; Carroceda S; Rosciupchin AES; Hernández SH; Cogorno L; Iturriaga AG; García DB
Radiat Oncol; 2024 May; 19(1):54. PubMed ID: 38702761
[TBL] [Abstract][Full Text] [Related]
5. Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial.
Hewson EA; Nguyen DT; O'Brien R; Poulsen PR; Booth JT; Greer P; Eade T; Kneebone A; Hruby G; Moodie T; Hayden AJ; Turner SL; Hardcastle N; Siva S; Tai KH; Martin J; Keall PJ
Radiother Oncol; 2020 Oct; 151():234-241. PubMed ID: 32828839
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic prostate adaptive radiotherapy utilising kilovoltage intrafraction monitoring: the TROG 15.01 SPARK trial.
Keall P; Nguyen DT; O'Brien R; Booth J; Greer P; Poulsen P; Gebski V; Kneebone A; Martin J
BMC Cancer; 2017 Mar; 17(1):180. PubMed ID: 28270121
[TBL] [Abstract][Full Text] [Related]
7. Real-Time 3D Image Guidance Using a Standard LINAC: Measured Motion, Accuracy, and Precision of the First Prospective Clinical Trial of Kilovoltage Intrafraction Monitoring-Guided Gating for Prostate Cancer Radiation Therapy.
Keall PJ; Ng JA; Juneja P; O'Brien RT; Huang CY; Colvill E; Caillet V; Simpson E; Poulsen PR; Kneebone A; Eade T; Booth JT
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1015-21. PubMed ID: 27026307
[TBL] [Abstract][Full Text] [Related]
8. The first clinical implementation of real-time image-guided adaptive radiotherapy using a standard linear accelerator.
Keall PJ; Nguyen DT; O'Brien R; Caillet V; Hewson E; Poulsen PR; Bromley R; Bell L; Eade T; Kneebone A; Martin J; Booth JT
Radiother Oncol; 2018 Apr; 127(1):6-11. PubMed ID: 29428258
[TBL] [Abstract][Full Text] [Related]
9. The first clinical implementation of a real-time six degree of freedom target tracking system during radiation therapy based on Kilovoltage Intrafraction Monitoring (KIM).
Nguyen DT; O'Brien R; Kim JH; Huang CY; Wilton L; Greer P; Legge K; Booth JT; Poulsen PR; Martin J; Keall PJ
Radiother Oncol; 2017 Apr; 123(1):37-42. PubMed ID: 28342648
[TBL] [Abstract][Full Text] [Related]
10. Kilovoltage intrafraction monitoring during normofractionated prostate cancer radiotherapy.
Chasseray M; Dissaux G; Lucia F; Boussion N; Goasduff G; Pradier O; Bourbonne V; Schick U
Cancer Radiother; 2020 Apr; 24(2):99-105. PubMed ID: 32201058
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
[TBL] [Abstract][Full Text] [Related]
12. Novel breath-hold liver target stereotactic ablative radiotherapy using the intrafraction diaphragm registration of kilovoltage projection streaming image with digitally reconstructed radiography of the planning computed tomography.
Katano A; Nozawa Y; Minamitani M; Yamashita H; Nakagawa K
Tech Innov Patient Support Radiat Oncol; 2023 Sep; 27():100217. PubMed ID: 37448787
[TBL] [Abstract][Full Text] [Related]
13. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
Ball D; Mai GT; Vinod S; Babington S; Ruben J; Kron T; Chesson B; Herschtal A; Vanevski M; Rezo A; Elder C; Skala M; Wirth A; Wheeler G; Lim A; Shaw M; Schofield P; Irving L; Solomon B;
Lancet Oncol; 2019 Apr; 20(4):494-503. PubMed ID: 30770291
[TBL] [Abstract][Full Text] [Related]
15. Technical advances in external radiotherapy for hepatocellular carcinoma.
Park SH; Kim JC; Kang MK
World J Gastroenterol; 2016 Aug; 22(32):7311-21. PubMed ID: 27621577
[TBL] [Abstract][Full Text] [Related]
16. Variation in Lung Tumour Breathing Motion between Planning Four-dimensional Computed Tomography and Stereotactic Ablative Radiotherapy Delivery and its Dosimetric Implications: Any Role for Four-dimensional Set-up Verification?
Ruben JD; Seeley A; Panettieri V; Ackerly T
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):21-7. PubMed ID: 26432188
[TBL] [Abstract][Full Text] [Related]
17. [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?].
Riou O; Valdenaire S; Debuire P; Fenoglietto P; Debrigode C; Mazard T; Assenat É; Aillères N; Azria D
Cancer Radiother; 2019 Oct; 23(6-7):636-650. PubMed ID: 31444078
[TBL] [Abstract][Full Text] [Related]
18. Simulated multileaf collimator tracking for stereotactic liver radiotherapy guided by kilovoltage intrafraction monitoring: Dosimetric gain and target overdose trends.
Poulsen PR; Murtaza G; Worm ES; Ravkilde T; O'Brien R; Grau C; Høyer M; Keall P
Radiother Oncol; 2020 Mar; 144():93-100. PubMed ID: 31786423
[TBL] [Abstract][Full Text] [Related]
19. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II.
Siva S; Chesson B; Bressel M; Pryor D; Higgs B; Reynolds HM; Hardcastle N; Montgomery R; Vanneste B; Khoo V; Ruben J; Lau E; Hofman MS; De Abreu Lourenco R; Sridharan S; Brook NR; Martin J; Lawrentschuk N; Kron T; Foroudi F
BMC Cancer; 2018 Oct; 18(1):1030. PubMed ID: 30352550
[TBL] [Abstract][Full Text] [Related]
20. Real-time intrafraction prostate motion during linac based stereotactic radiotherapy with rectal displacement.
Legge K; Nguyen D; Ng JA; Wilton L; Richardson M; Booth J; Keall P; O'Connor DJ; Greer P; Martin J
J Appl Clin Med Phys; 2017 Nov; 18(6):130-136. PubMed ID: 28960696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
